HFB-100204 is a humanized monoclonal antibody (mAb) targeting CXCR5. It reduces CXCR5+ immune cells, including B cells and Tfh cells, in the blood and spleen of hCXCR5 knockout mice. HFB-100204 is applicable for research focused on autoimmune diseases.
Target-Kategorie:
CXCR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten